Ribosomal Protein L19 Is a Prognostic Marker for Human Prostate Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-2445
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Expression Status of Cyclase‑associated Protein 2 as a Prognostic Marker for Human Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2016English

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Correction: Genomic Deletion of Chromosome 12p Is an Independent Prognostic Marker in Prostate Cancer

Oncotarget
Oncology
2017English

Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer

PLoS ONE
Multidisciplinary
2016English

L1TD1 - A Prognostic Marker for Colon Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients

Contrast Media and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2018English

Minichromosome Maintenance Protein 7 Is a Potential Therapeutic Target in Human Cancer and a Novel Prognostic Marker of Non-Small Cell Lung Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2011English

The Intercellular Adhesion Molecule, Cadherin-10, Is a Marker for Human Prostate Luminal Epithelial Cells That Is Not Expressed in Prostate Cancer

Modern Pathology
Forensic MedicinePathology
2007English

Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy